TL;DR — The $725 standard ACP member rate is the single largest registration bucket at Internal Medicine Meeting 2026 — roughly 4,000-6,000 attendees out of the meeting's 8,000-10,000 total. Who pays $725? Board-certified attending internists in active clinical practice: general internists, hospitalists, primary care internists, and internal medicine subspecialists with full ACP membership. They write prescriptions, order diagnostics, refer to subspecialists, and influence formulary and capital purchasing inside their health systems. For drug, device, diagnostic, digital health, and AI exhibitors selling into adult medicine, the $725 attendee is the highest-leverage audience segment at the meeting — but they walk past consumer-style booth experiences. Clinical-evidence-first booth strategy, pre-show physician outreach, and post-show CME-linked follow-up are what convert this audience into pipeline.
What the $725 Number Actually Tells You
The $725 standard ACP member rate at Internal Medicine Meeting 2026 is more than a line item on a registration page — it is a self-selection filter. Every attendee paying $725 has made three implicit decisions: they hold ACP membership in good standing, they prioritized in-person CME over the lower-cost on-demand alternatives ACP publishes through the year, and they chose the standard tier over the $1,175 premium tier because they did not need the premium add-ons. That triple-filter produces a distinct audience profile that is worth understanding before you commit booth dollars, sponsorship spend, or pre-show outreach budget to ACP.
This guide is written for exhibitors and brand teams. If you are an attending internist trying to decide between the $725 standard tier and the $1,175 premium tier, our companion ACP Internal Medicine Meeting 2026 rates for ACP members guide covers the registration math from the attendee side.
The $725 Attendee in One Sentence
The $725 ACP member at Internal Medicine Meeting 2026 is a credentialed, board-certified attending internist in active clinical practice who pays for clinical education themselves or through a structured CME stipend and arrives expecting peer-reviewed evidence rather than promotional content. That sentence carries the entire commercial brief — every booth, message, and follow-up cadence has to honor those expectations or it underperforms.
Segment Size: How Many $725 Attendees Are Actually There?
ACP Internal Medicine Meeting typically draws 8,000-10,000 total attendees. The $725 standard ACP member tier is the single largest registration bucket inside that total. Most attending internists pick standard over premium because their use case is core didactic sessions plus exhibit hall — they do not need premium pre-courses, simulation lab time, or year-round on-demand session libraries. Realistic estimates:
- $725 standard member tier: 4,000-6,000 attendees (50-60% of total registration)
- $1,175 premium member tier: 1,200-2,000 attendees
- $1,386 non-member tier: 600-1,200 attendees
- Resident, fellow, and student tiers: 1,500-2,500 attendees
- International, comp, and faculty: remainder
For exhibitor planning purposes, treat the $725 segment as the dominant adult-medicine prescriber and order-writer audience at the meeting. If your in-booth message, pre-show outreach, and follow-up cadence are not designed for this segment, you are designing for a minority of attendees.
Demographic and Practice Profile
The composite picture of a typical $725 attendee, built from ACP membership demographics and historical Internal Medicine Meeting attendance data:
| Dimension | Typical $725 attendee |
|---|---|
| Role | Attending physician, board-certified in internal medicine or an IM subspecialty |
| Practice setting | Mix of health system employment, multi-specialty group, academic medical center, and independent practice |
| Career stage | Heaviest concentration mid-career (5-20 years post-training), with strong tails into early and late career |
| Subspecialty mix | General internal medicine, hospital medicine, primary care, cardiology, GI, endocrinology, infectious disease, geriatrics, nephrology, pulmonary, rheumatology, hematology-oncology |
| Prescribing volume | Hundreds of prescriptions per month for chronic and acute oral therapeutics |
| Diagnostic ordering | High-volume orderer for lab panels, imaging, cardiac workup, and chronic disease monitoring |
| Referral influence | Direct gatekeeper for referrals into surgical, procedural, oncology, behavioral health, and specialty consult care |
| Purchasing authority | Voting input on EHR add-ons, formulary changes, point-of-care devices, and group-practice capital purchases |
| CME mindset | Self-funded or stipend-funded; arrives expecting peer-led evidence, not promotional content |
What the $725 Attendee Buys, Orders, and Influences
The commercial leverage in this segment comes from how many decisions one attending internist touches per year. A representative $725 attendee influences:
- Oral therapeutics — cardiometabolic (statins, antihypertensives, SGLT2s, GLP-1s), GI (PPIs, biologics for IBD), infectious disease (oral antibiotics, antivirals), behavioral health (SSRIs, SNRIs), and chronic disease management across the IM panel.
- Injectable and infused therapeutics — biologics, vaccines, infused therapies for chronic disease where the internist initiates or maintains therapy.
- Diagnostics — high-volume orderer for lab panels, cardiac workup, imaging, sleep studies, cancer screening, and specialty diagnostics.
- Point-of-care devices — handheld ultrasound, continuous glucose monitoring, continuous blood pressure, remote patient monitoring, ECG-on-device, otoscopes and stethoscopes with AI assist.
- Digital health and AI tools — EHR-integrated clinical decision support, AI scribes, patient messaging tools, asynchronous care platforms, and digital therapeutics.
- Specialty referral pathways — the internist is the gatekeeper for referrals into cardiology, GI, oncology, surgical specialties, and behavioral health.
- Formulary and capital input — health system formulary committees, group purchasing decisions, and capital equipment requests pass through attending internists as voting members or strong influencers.
If your product sits anywhere in that decision surface area, the $725 ACP attendee is a direct buyer, prescriber, or order-writer. The challenge is reaching them in a way they will engage with.
How the $725 Attendee Spends the Meeting
The typical $725 attendee's four-day in-meeting itinerary skews heavily toward didactic education and a smaller, targeted slice of exhibit floor time:
- 60-70% of time: general sessions, multitrack clinical updates, and ACP's signature recertification-relevant content. This is the core ACP value proposition and the reason they paid $725.
- 15-20% of time: exhibit hall — concentrated in the dedicated exhibit hours between sessions and during meal breaks. Most attendees walk the floor with a clinical agenda, not a shopping agenda.
- 10-15% of time: networking — peer connections inside specialty interest groups, regional ACP chapter contacts, residency program reunions, and informal hallway exchanges.
- 5-10% of time: off-floor satellite events, industry-sponsored symposia, dinner programs, and CME-credentialed workshops.
The implication for exhibitors: the exhibit floor is not where most attendee attention lives, and the $725 attendee is not browsing in a consumer mode. Booth strategy has to earn its share of that 15-20% time slice with clinical relevance, not interrupt it with promotional volume.
Booth Strategy That Actually Works on the $725 Attendee
The brands that consistently produce qualified pipeline from ACP Internal Medicine Meeting share a small number of habits. The $725 attendee tolerates very little friction between their CME agenda and a booth conversation, so winning approaches reduce that friction and increase clinical credibility:
- Lead with peer-reviewed evidence. The first thing visible from the aisle should reference clinical data — landmark trial, guidelines change, real-world outcomes. Not a product hero shot. Not a tagline.
- Staff with clinical specialists. Medical affairs, clinical specialists, MSLs, and clinical educators outperform commercial reps on this floor. The $725 attendee asks clinical questions and wants clinical answers.
- Pre-book targeted physician meetings. Pre-show outreach to a curated list of attending internists — KOLs, formulary chairs, system medical directors, ACP committee members — produces more pipeline than open-floor walk-up alone. See our pre-conference email campaigns guide for the cadence that works.
- Design for the 15-20% time slice. Booth content should pay off in 60-90 seconds for a passing attendee and have a structured deeper-dive for the 5-7 minutes a qualified prospect will give you. Our medical conference booth design playbook covers the layout details.
- Connect to CME where possible. Industry-supported symposia that produce CME credit at the meeting and follow-on enduring CME post-meeting build a reason for the attendee to engage with your brand beyond the four days in San Francisco.
- Build a post-show clinical follow-up cadence. The $725 attendee returns to clinic with a backlog. Generic post-show emails get archived. Clinical-content follow-ups — guideline summaries, trial deep-dives, peer roundtables — re-engage them.
Booth ROI Math: What's an $725 Attendee Actually Worth?
The exhibitor question we get most often: what is one $725 ACP attendee actually worth in pipeline terms? The honest answer depends on category, price point, and sales cycle length, but a directional model works for most adult-medicine vendors:
- Oral therapeutic, $4,000-$15,000 annual cost per patient: one engaged $725 attendee who adopts your product as standard for an appropriate patient subgroup generates 20-80 starts per year. At net realized pricing, the lifetime revenue per converted internist runs in the low-to-mid six figures.
- Specialty injectable or biologic: a single converted internist generating 5-15 starts per year produces six-to-seven-figure lifetime value depending on therapy area.
- Point-of-care device, $3,000-$50,000 capital cost: one converted internist or one practice purchase decision typically pays back the cost of attending the meeting for the entire booth team.
- Digital health or AI subscription, $200-$2,000 per provider per month: a single multi-provider practice signed at the meeting recoups booth spend within 60-90 days of contract start.
The framing problem most exhibitors run into at ACP is treating the meeting as a brand-awareness investment when it is actually a high-conversion clinical buyer environment. Designed properly, an ACP booth program built around the $725 attendee profile produces measurable pipeline, not just impressions. Our medical conference marketing ROI framework covers the modeling in depth.
What Not To Do
A short list of the booth habits that visibly cost exhibitors $725-attendee engagement:
- Promotional games, giveaways without clinical pretext, or consumer-style displays. The $725 attendee paid for clinical CME. Carnival-style booths read as a mismatch and get walked past.
- Junior commercial reps as primary booth staff. The $725 attendee asks clinical questions on first contact. If your booth cannot answer at the clinical level inside 30 seconds, you lose the conversation.
- Long-form lead capture before any value exchange. Multi-field forms before a download or demo lose 70-90% of attendees who would have engaged with a one-click QR-to-content path.
- No pre-show outreach. Exhibitors who show up cold on day one and rely on floor walk-up alone systematically underperform exhibitors who pre-book physician meetings, send pre-show content, and warm a target list before the meeting opens.
- Generic post-show follow-up. "Thanks for visiting our booth" emails archive immediately. The $725 attendee will only re-engage with clinical content that respects the reason they paid $725 in the first place.
Final Take: Treat $725 as a Self-Selection Signal
The $725 standard ACP member rate at Internal Medicine Meeting 2026 is the largest single segment at one of the highest-leverage adult-medicine meetings in the U.S. Every attendee inside that segment is a credentialed attending internist who self-selected into peer-led clinical education and brings real prescribing, ordering, and referral authority back to their practice on Monday. The exhibitors that produce pipeline from ACP are the ones who design every touchpoint — booth, pre-show outreach, in-meeting symposia, and post-show follow-up — around that profile. The exhibitors who underperform are the ones who designed for an audience that is not actually in the room.
If you are evaluating ACP 2026 as a marketing investment or building out your booth program for the Moscone Center, the $725 attendee profile is the right anchor for every commercial decision in the plan.